Skip to main content
Clinical Trials/ChiCTR1900021297
ChiCTR1900021297Not yet recruiting回顾性研究

舒芬太尼联合右美托咪定、氟比洛芬酯用于胃肠手术术后镇痛效果的回顾性分析

研究者自费1 site in 1 country1,000 target enrollmentStarted: March 1, 2019Last updated:

Trial Snapshot

Phase
回顾性研究
Status
Not yet recruiting
Sponsor
Enrollment
1,000
Locations
1
Primary Endpoint
术后 24h/48h 静息 VAS 疼痛评分和活动疼痛评分

Study Overview

Brief Summary

评价舒芬太尼联合右美托咪定,氟比洛芬酯用于胃肠手术术后镇痛镇痛效果及安全性。

Study Design

Study Type
观察性研究
Primary Purpose
单臂
Masking
N/a

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 术后接受舒芬太尼联合右美托咪啶,氟比洛芬酯静脉自控镇痛治疗。

Exclusion Criteria

  • 冠心病患者,冠心病支架安置者,重度心力衰竭患者,严重肝肾及血液系统功能障碍患者,

Arms & Interventions

Case Series

舒芬太尼联合右美托咪定,氟比洛芬酯用于胃肠手术术后镇痛

Outcomes

Primary Outcomes

术后 24h/48h 静息 VAS 疼痛评分和活动疼痛评分

Secondary Outcomes

  • 恶心呕吐发生率

Investigators

Sponsor
研究者自费

Study Sites (1)

Loading locations...

Similar Trials